ABSTRACT
Objective: To establish a method for the induction of peripheral blood mononuclear cells to hepatocyte-like cells, and preliminarily investigate cell response to injury under the effect of acetaminophen (APAP). Methods: The surface marker CD45 of peripheral blood mononuclear cells wase detected cells by using flow cytometry and immunofluorescence methods. The cellular morphology of induced hepatocyte-like cells was observed under an inverted microscope. Real-time fluorescent quantitative PCR (RT-PCR) was used to detect the expression level of hepatocyte-specific genes, such as cytochrome (CY) P1A2, CYP3A4, CYP2C9, albumin (ALB), alpha-fetoprotein (AFP), and hepatocyte nuclear factor (HNF)4α mRNA. Immunofluorescence method was used to detect intracellular hepatocyte markers AFP, HNF4α, and ALB expression at the protein level. Biochemical analyzer was used to detect hepatocyte-specific secretory functions of AFP, ALB, and urea. Luciferase chemiluminescence method was used to detect the activity of key drug metabolizing enzyme CYP3A4. Colorimetric assay was used to detect the effect of the drug acetaminophen on hepatocyte-like cells, and alanine aminotransferase (ALT) was used as an indicator of liver cell injury. The statistical differences between the data were compared with t-test and rank-sum test. Results: The positive expression rate of CD45 cell surface markers isolated from peripheral blood mononuclear cells was about 98%, and hepatocyte-like cell morphology changes appeared on 15th day of induction. Compared with isolated mononuclear cells, CYP1A2, CYP3A4, CYP2C9, ALB, AFP and HNF4α mRNA was markedly elevated. The expression level of AFP, ALB and HNF4α protein were equally increased, and the secretory function of AFP, ALB and urea were enhanced. Compared with primary hepatocytes, CYP1A2, CYP2C9, AFP, HNF4α mRNA, and CYP3A4 mRNA did not decrease. The expression levels of AFP, ALB, and HNF4α proteins in the cells did not decrease, and the secretory function of AFP, ALB, and urea did not decrease. In addition, the CYP3A4 enzyme activity produced by hepatocyte-like cells was similar to that of primary hepatocytes. Compared with hepatocyte-like cells incubated without APAP, hepatocyte-like cells incubated with APAP had higher ALT level. Under the effect of APAP, the ALT level of hepatocyte-like cells was higher than isolated mononuclear cells. Conclusion: Peripheral blood mononuclear cells can be induced into hepatocyte-like cells with partial characteristics of hepatocytes, including the activity of CYP3A4, a key enzyme of hepatocyte drug metabolism. Additionally, preliminarily ALT secretory features reflect the hepatocytes injury under the effect of acetaminophen.
Subject(s)
Acetaminophen/pharmacology , Cell Differentiation , Cells, Cultured , Hepatocytes , Leukocytes, Mononuclear , RNA, MessengerABSTRACT
ABSTRACT Generally speaking, the physiological index of the human body is in a relatively stable state, which refers to the function of various organ systems with the characteristics of high-tide period, low-tide period and critical period. However, for competitive athletes, it is necessary to maintain physiological activation in both training and competition. In view of this, this study will analyze the physiological arousal degree of aspirin and acetaminophen in order to provide a reference for athletes to take analgesic drugs. In this study, the analytic hierarchy process (AHP), principal component analysis and factor analysis, were used to construct a scientific evaluation system of physiological arousal level, and the medication and non-medication status of 90 athletes were evaluated. The results showed that aspirin was better than acetaminophen in blood urea and serum creatine kinase, and the comprehensive score of some athletes was higher than 0.95. Aspirin is better in arousing athletes' physiology. The research results will provide scientific guidance for athletes to take antipyretic and analgesic drugs.
RESUMO Em termos gerais, o índice fisiológico do corpo humano encontra-se num estado relativamente estável, que se refere à função de vários sistemas de órgãos no corpo humano, com as características do período de altas, período de baixas e período crítico. No entanto, para atletas competitivos, é necessário manter a ativação fisiológica em treinamento e competição. Em vista disso, este estudo irá analisar o grau fisiológico de excitação de aspirina e acetaminofeno, a fim de fornecer referência para os atletas a tomar medicamentos analgésicos. Neste estudo, o Analytic Hierarchy Process (AHP), análise de componentes principal e análise de fatores foram usados para construir um sistema de avaliação científica de nível de excitação fisiológica, e o estado de medicação e de não medicação de 90 atletas foram avaliados. Os resultados mostraram que a aspirina foi melhor do que o acetaminofeno na ureia sanguínea e na creatina quinase sérica, e o escore abrangente de alguns atletas foi maior do que 0.95. A aspirina é melhor no despertar da fisiologia dos atletas. Os resultados da pesquisa fornecerão orientação científica para os atletas tomarem medicamentos antipiréticos e analgésicos.
RESUMEN En términos generales, el índice fisiológico del cuerpo humano se encuentra en un estado relativamente estable, que se refiere a la función de varios sistemas de órganos en el cuerpo humano, con las características del período de altas, período de bajas y período crítico. Mientras tanto, para atletas competitivos, es necesario mantener la activación fisiológica en entrenamiento y competición. En vista de eso, este estudio analizará el grado fisiológico de excitación de aspirina y acetaminofeno, a fin de proveer referencia para los atletas para tomar medicamentos analgésicos. En este estudio, el Analytic Hierarchy Process (AHP), análisis de componentes principal y análisis de fatores fueron usados para construir un sistema de evaluación científica de nivel de excitación fisiológica, y el estado de medicación y de no medicación de 90 atletas fueron evaluados. Los resultados mostraron que la aspirina fue mejor que el acetaminofeno en la urea sanguínea y en la creatina quinasa sérica, y el escore abarcador de algunos atletas fue mayor de 0.95. La aspirina es mejor en el despertar de la fisiología de los atletas. Los resultados de la investigación proveerán orientación científica para que los atletas tomen medicamentos antipiréticos y analgésicos.
Subject(s)
Humans , Adolescent , Young Adult , Track and Field/physiology , Aspirin/pharmacology , Analgesics, Non-Narcotic/pharmacology , Athletes , Acetaminophen/pharmacologyABSTRACT
Abstract Objective: The injury-reducing effect of acetaminophen, an effective analgesic and antipyretic on ischemia-reperfusion continues to attract great attention. This study analyzed the protective effect of acetaminophen on myocardial injury induced by ischemia-reperfusion in an experimental animal model from lower extremity ischemia-reperfusion. Methods: Twenty-four Sprague-Dawley female rats were randomized into three groups (n=8) as (i) control group (only laparotomy), (ii) aortic ischemia-reperfusion group (60 min of ischemia and 120 min of reperfusion) and (iii) ischemia-reperfusion + acetaminophen group (15 mg/kg/h intravenous acetaminophen infusion starting 15 minutes before the end of the ischemic period and lasting till the end of the reperfusion period). Sternotomy was performed in all groups at the end of the reperfusion period and the heart was removed for histopathological examination. The removed hearts were histopathologically investigated for myocytolysis, polymorphonuclear leukocyte (PMNL) infiltration, myofibrillar edema and focal hemorrhage. Results: The results of histopathological examination showed that acetaminophen was detected to particularly diminish focal hemorrhage and myofibrillar edema in the ischemia-reperfusion + acetaminophen group (P<0.001, P=0.011), while there were no effects on myocytolysis and PMNL infiltration between the groups (P=1.000, P=0.124). Conclusion: Acetaminophen is considered to have cardioprotective effect in rats, by reducing myocardial injury induced by abdominal aortic ischemia-reperfusion.
Subject(s)
Humans , Animals , Female , Cardiotonic Agents/pharmacology , Myocardial Reperfusion Injury/prevention & control , Lower Extremity/blood supply , Acetaminophen/pharmacology , Aorta, Abdominal/pathology , Reference Values , Time Factors , Myocardial Reperfusion Injury/pathology , Random Allocation , Rats, Sprague-Dawley , Constriction , Disease Models, Animal , Edema, Cardiac/pathology , Ischemia/prevention & control , Ischemia/blood , Myofibrils/pathologyABSTRACT
ABSTRACT The present study aimed to perform a systematic literature review to determine if there is a non-steroidal anti-inflammatory drug (NSAID) that interferes less within tooth movement. This research was performed according to the PRISMA statement. Articles were searched in eight electronic databases (PubMed, Scopus, Embase, Web of Science, LILACS, SciELO, Google Scholar, and Open Grey). Only experimental studies on male Wistar rats were selected, which included experiments related to the influence of NSAIDs on orthodontic movement. Studies in animals with pathological conditions, literature review articles, letters to the editor and/or editorials, case reports, abstracts, books, and book chapters were excluded. Each of the steps of this systematic literature review was performed by two examiners independently. Results: the total sample consisted of 505 articles, from which 6 studies were eligible after a qualitative analysis. From the drugs assessed, paracetamol was unanimous for not interfering within orthodontic movement when compared to the control group. However, drugs such as aspirin, ibuprofen, sodium diclofenac, and selective cyclooxygenase-2 inhibitors caused a reduction in tooth movement when compared to the control group. Conclusion: paracetamol could be considered the drug of choice for pain relief because it interferes less within tooth movement.
Subject(s)
Animals , Rats , Tooth Movement Techniques/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Ibuprofen/pharmacology , Analgesics, Non-Narcotic/pharmacology , Pain, Procedural/drug therapy , Acetaminophen/pharmacology , Rats, Wistar , Disease Models, AnimalABSTRACT
Una de las principales preocupaciones de los pacientes que van a ser sometidos a un procedimiento odontológico es el dolor que dicho procedimiento pueda ocasionar. Por lotanto, lograr un control eficaz y seguro de ese dolor es una parte esencial de la práctica odontológica diaria. Los fármacos de primera elección para el tratamiento del dolor y el edemason, sin lugar a dudas, los antiinflamatorios no esteroideos(AINEs). Principios activos como el ibuprofeno (y sus congéneres) o sus derivados permiten controlar simultáneamente el dolor y el edema posquirúrgicos de una forma eficaz y segura. En muchas ocasiones, el AINE prescrito para mantener al paciente asintomático o con síntomas tolerables es suficiente. Sin embargo, cuando esto no ocurre, debemos recurrir a otrosfármacos, o realizar asociaciones con fármacos que complementen el efecto analgésico y trabajen logrando un sinergismo de potenciación que incremente el efecto buscado y disminuya los efectos adversos de cada una de las sustancias por separado, utilizando menores dosis. Un ejemplo comprobado de esas asociaciones es la de ibuprofeno con paracetamol. En el presente artículo se sugieren diversas estrategias pre- y posoperatorias para el manejo del dolor de origen inflamatorio, y un protocolo para su tratamiento.
Subject(s)
Humans , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Pain, Postoperative/drug therapy , Ibuprofen/pharmacology , Acetaminophen/pharmacology , Drug Combinations , Drug Synergism , Dosage Forms , Analgesics/pharmacology , Analgesics/pharmacokinetics , Analgesics/therapeutic useABSTRACT
The antipyretic effect of the aqueous extract of herbal coded formulation containing equal amount of Salix alba, Emblica officinalis, Glycyrrhiza glabra, Adhatoda vasica, Viola odorata, Thea sinensis, Veleriana officinalis, Foeniculum vulgare, Sisymbrium irrio and Achillea millefolium was investigated using the yeast induced pyrexia model in rabbits. Paracetamol was used as a control group. Rectal temperatures of all rabbits were recorded immediately before the administration of the extract or paracetamol and again at 1 hour, after this, temperature was noted at 1 hrs interval for 5 hrs using digital thermometer. At 240 mg/kg dose the extract showed significant reduction in yeast-induced elevated temperature as compared with that of standard drug paracetamol [150 mg/kg]. It is concluded that herbal coded medicine at a dose of 240 mg/kg has marked antipyretic activity in animal models and this strongly supports the ethno pharmacological uses of medicinal plants of this formulation
Subject(s)
Animals, Laboratory , Antipyretics/pharmacology , Acetaminophen/pharmacology , Body Temperature Regulation/drug effects , Phytotherapy , Plants, Medicinal , RabbitsABSTRACT
Abstract The objective of this study was to evaluate the action of Hymenaea stigonocarpa bark hydroalcoholic extract against a mutagenic compound using A. cepa meristematic root cells as a test system. The treatment groups were: Negative Control (NC) – distilled water; Positive Control (PC) – paracetamol at a concentration of 0.008 mg/mL, Jatoba Control (JC) – aqueous fraction jatobá-do-cerrado at 0.5 or 1.0 or 1.5 mg/mL, and Simultaneous Treatment (ST) - jatobá-do-cerrado aqueous fraction at a concentration of 0.5 or 1.0 or 1.5 mg/mL associated with paracetamol solution at a concentration of 0.008 mg/mL. All groups were analyzed at 24 and 48 h. Five onion bulbs (five replications) were used for each treatment group. The root tips were fixed in Carnoy and slides prepared by the crush technique. Cells were analyzed throughout the cell cycle, totaling 5,000 for each treatment group at each exposure time. Mitotic indices were subjected to statistical analysis using the chi-square test (p<0.05). From the results it was found that the ST group, at the three concentrations, significantly potentiated the antiproliferative effect of the test system cells when compared to PC, NC and TJ at the three concentrations. Furthermore, the three ST concentrations significantly reduced the number of cell aberrations when compared to the number of aberrant cells obtained for the PC, demonstrating antimutagenic action on the A. cepa test system cells.
Resumo O objetivo do presente trabalho foi avaliar a ação do extrato hidroalcólico do ritidoma de Hymenaea stigonocarpa frente a um composto mutagênico, utilizando como sistema teste as células meristemáticas de raízes de A. cepa. Os grupos tratamentos avaliados foram: Controle Negativo (CN) – água destilada; Controle Positivo (CP) – paracetamol na concentração de 0,008 mg/mL, Controle Jatobá (CJ) – fração aquosa de jatobá-do-cerrado na concentração de 0,5 ou 1,0 ou 1,5 mg/mL, e Tratamento Simultâneo (TS) – fração aquosa de jatobá-do-cerrado na concentração de 0,5 ou 1,0 ou 1,5 mg/mL associada a solução de paracetamol na concentração de 0,008 mg/mL. Todos os grupos foram analisados nos tempos de 24 e 48 h. Para cada grupo tratamento cinco bulbos de cebolas (cinco repetições) foram utilizados. As radículas foram fixadas em Carnoy e as lâminas preparadas pela técnica de esmagamento. Analisaram-se células em todo ciclo celular, totalizando 5.000 para cada grupo tratamento em cada tempo de exposição. Os índices mitóticos obtidos foram submetidos à análise estatística do Qui-quadrado (p<0,05). A partir dos resultados verificou-se que o grupo TS, nas três concentrações, potencializou o efeito antiproliferativo significativo as células do sistema teste quando comparado ao CP, CN e TJ nas três concentrações. Ainda, o TS nas três concentrações reduziu de forma significativa o número de aberrações celulares quando comparado com o número de células aberrantes obtidas para o CP, demonstrando ação antimutagênica as células do sistema teste A. cepa.
Subject(s)
Plant Extracts/pharmacology , Onions/cytology , Onions/physiology , Hymenaea , Acetaminophen/pharmacology , Time Factors , Cell Cycle/drug effects , Meristem , Plant Bark , Antimitotic Agents/pharmacology , Antipyretics/pharmacology , Mitotic Index/methods , Mutagens/metabolism , Mutagens/pharmacologyABSTRACT
PURPOSES: To determine the basic expression of ABC transporters in an epithelial ovarian cancer cell line, and to investigate whether low concentrations of acetaminophen and ibuprofen inhibited the growth of this cell line in vitro. METHODS: TOV-21 G cells were exposed to different concentrations of acetaminophen (1.5 to 15 μg/mL) and ibuprofen (2.0 to 20 μg/mL) for 24 to 48 hours. The cellular growth was assessed using a cell viability assay. Cellular morphology was determined by fluorescence microscopy. The gene expression profile of ABC transporters was determined by assessing a panel including 42 genes of the ABC transporter superfamily. RESULTS: We observed a significant decrease in TOV-21 G cell growth after exposure to 15 μg/mL of acetaminophen for 24 (p=0.02) and 48 hours (p=0.01), or to 20 μg/mL of ibuprofen for 48 hours (p=0.04). Assessing the morphology of TOV-21 G cells did not reveal evidence of extensive apoptosis. TOV-21 G cells had a reduced expression of the genes ABCA1, ABCC3, ABCC4, ABCD3, ABCD4 and ABCE1 within the ABC transporter superfamily. CONCLUSIONS: This study provides in vitro evidence of inhibitory effects of growth in therapeutic concentrations of acetaminophen and ibuprofen on TOV-21 G cells. Additionally, TOV-21 G cells presented a reduced expression of the ABCA1, ABCC3, ABCC4, ABCD3, ABCD4 and ABCE1 transporters. .
OBJETIVOS: Determinar a expressão básica dos transportadores ABC em uma linhagem celular do câncer epitelial de ovário, e investigar se o acetaminofen e o ibuprofeno em baixas concentrações são capazes de inibir o crescimento desta linhagem celular in vitro. MÉTODOS: A linhagem celular TOV-21 G foi exposta a diferentes concentrações de acetaminofen (1,5 a 15 µg/mL) e ibuprofeno (2,0 a 20 µg/mL), de 24 a 48 horas. O crescimento celular foi avaliado utilizando-se um ensaio de viabilidade celular. A morfologia celular foi determinada por meio da microscopia de fluorescência. O perfil de expressão gênica foi estabelecido por um painel de 42 genes da superfamília de transportadores ABC. RESULTADOS: Observou-se um decréscimo significativo no crescimento das células TOV-21 G expostas a 15 µg/mL de acetaminofen durante 24 (p=0,02) e 48 horas (p=0,01), ou a 20 µg/mL de ibuprofeno por 48 horas (p=0,04). Ao avaliar a morfologia das células cultivadas, não foi observada evidência de apoptose extensiva. A linhagem de células estudada subexpressa os genes de ABCA1, ABCC3, ABCC4, ABCD3, ABCD4 e ABCE1 na superfamília de transportadores ABC. CONCLUSÕES: Este estudo fornece evidências in vitro referentes aos efeitos inibidores do crescimento de concentrações terapêuticas do acetaminofen e ibuprofeno na linhagem celular testada. Além disso, as células TOV-21 G apresentaram uma expressão reduzida de genes dos transportadores ABCA1, ABCC3, ABCC4, ABCD3, ABCD4 e ABCE1. .
Subject(s)
Humans , Female , Acetaminophen/pharmacology , ATP-Binding Cassette Transporters/genetics , Cell Proliferation/drug effects , Ibuprofen/pharmacology , Neoplasms, Glandular and Epithelial/genetics , Neoplasms, Glandular and Epithelial/pathology , Ovarian Neoplasms/genetics , Ovarian Neoplasms/pathology , Transcriptome/drug effects , Cell Line, Tumor , Cell Survival/drug effects , Tumor Cells, CulturedABSTRACT
Os anti-inflamatórios não esteroidais (AINEs) são medicamentos utilizados no alívio da dor após a ativação dos aparelhos ortodônticos, mas estas substâncias podem influenciar a formação óssea ou remodelação. Diante da possibilidade de interferência dos medicamentos durante o tratamento ortodôntico, foi avaliado o efeito á curto prazo de AINEs e anti-inflamatório seletivo COX-2, em doses terapêuticas, sobre osteoblastos durante a movimentação dentária induzida. Os fármacos foram determinados através de questionários aplicados a ortodontistas, os quais mais selecionaram os mais prescritos para alívio da dor durante o tratamento ortodôntico. Os medicamentos selecionados e a nimesulida (seletivo COX-2) foram administrados em uma amostra de 80 ratos albinos da linhagem Wistar, nos quais foi realizada a instalação de dispositivos constituídos por uma mola de secção fechada ancorada aos incisivos centrais superiores, movimentando mesialmente o primeiro molar superior esquerdo. Os animais foram distribuídos em quatro grupos de 20 de acordo com a administração medicamentosa diária: paracetamol, ibuprofeno, nimesulida e um grupo controle (animais não medicados). E divididos em subgrupos de 5 de acordo com o tempo de tratamento da movimentação dentária induzida: 3, 5 e 7 dias. Posteriormente, os animais receberam doses letais da mistura de relaxante muscular e anestésico por via intramuscular para coleta do material, o qual foi devidamente processado, corado com hematoxilina-eosina e submetido à análise microscópica óptica para avaliar a quantidade de osteoblastos, na área de tensão, do osso adjacente de cada raiz distovestibular dos primeiros molares superiores esquerdo. Os resultados mostraram que o uso de paracetamol até 5 dias pode gerar interferências na formação óssea, pois diminuiu o número de osteoblastos e que o ibuprofeno foi a droga que melhor agiu por apresentar menor ação de inibição sobre os osteoblastos num período de uso de até...
The nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs used to relieve pain after activation of orthodontic appliances, but these substances can influence bone remodeling and formation. Faced with the possibility of interference of drugs in treatments, the effects will be short-term NSAIDs and COX-2 selective antiinflammatory in therapeutic doses on osteoblasts during induced tooth movement. The drugs were determined through questionnaires given to orthodontists, selecting then, the most commonly prescribed for pain relief during orthodontic treatment. The selected drugs and nimesulide (selective COX-2) were administered in a sample of 80 albino Wistar rats, in which the installation of devices consisted of an enclosed section spring anchored to the upper central incisors, moving out mesially the first upper left molar. The animals were divided into four groups of 20 according to the daily drug administration: acetaminophen, ibuprofen, nimesulide and a control group (animals not treated). Then, divided into subgroups of 5 according to the treatment time of the induced tooth movement, 3, 5 and 7 days. Subsequently, the animals received lethal doses of the mixture of anesthetic and muscle relaxant intramuscularly for the collection of the material, which has been properly processed, stained with hematoxylin-eosin and subjected to microscopic analysis to assess the amount of osteoblasts in the stressed area of the adjacent bone of each distobuccal root of the first left molars. The results showed that the use of acetaminophen up to 5 days will cause interference in bone formation decreasing the number of osteoblasts and ibuprofen was the drug that best acted by having less inhibiting action on osteoblasts in a usage period of up to 7 days. It is suggested that the ideal to relieve pain and/or discomfort caused by orthodontic movement without prejudice to the bone repair would be the use of the associated medication. On the first day, use acetaminophen...
Subject(s)
Animals , Male , Rats , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , /pharmacology , Tooth Movement Techniques , Osteoblasts , Sulfonamides/pharmacology , Acetaminophen/pharmacology , Ibuprofen/pharmacology , Osteogenesis , Rats, Wistar , Time FactorsABSTRACT
Os anti-inflamatórios não esteroidais (AINEs) são medicamentos utilizados no alívio da dor após a ativação dos aparelhos ortodônticos, mas estas substâncias podem influenciar a formação óssea ou remodelação. Diante da possibilidade de interferência dos medicamentos durante o tratamento ortodôntico, foi avaliado o efeito á curto prazo de AINEs e anti-inflamatório seletivo COX-2, em doses terapêuticas, sobre osteoblastos durante a movimentação dentária induzida. Os fármacos foram determinados através de questionários aplicados a ortodontistas, os quais mais selecionaram os mais prescritos para alívio da dor durante o tratamento ortodôntico. Os medicamentos selecionados e a nimesulida (seletivo COX-2) foram administrados em uma amostra de 80 ratos albinos da linhagem Wistar, nos quais foi realizada a instalação de dispositivos constituídos por uma mola de secção fechada ancorada aos incisivos centrais superiores, movimentando mesialmente o primeiro molar superior esquerdo. Os animais foram distribuídos em quatro grupos de 20 de acordo com a administração medicamentosa diária: paracetamol, ibuprofeno, nimesulida e um grupo controle (animais não medicados). E divididos em subgrupos de 5 de acordo com o tempo de tratamento da movimentação dentária induzida: 3, 5 e 7 dias. Posteriormente, os animais receberam doses letais da mistura de relaxante muscular e anestésico por via intramuscular para coleta do material, o qual foi devidamente processado, corado com hematoxilina-eosina e submetido à análise microscópica óptica para avaliar a quantidade de osteoblastos, na área de tensão, do osso adjacente de cada raiz distovestibular dos primeiros molares superiores esquerdo. Os resultados mostraram que o uso de paracetamol até 5 dias pode gerar interferências na formação óssea, pois diminuiu o número de osteoblastos e que o ibuprofeno foi a droga que melhor agiu por apresentar menor ação de inibição sobre os osteoblastos num período de uso de até...
The nonsteroidal anti-inflammatory drugs (NSAIDs) are drugs used to relieve pain after activation of orthodontic appliances, but these substances can influence bone remodeling and formation. Faced with the possibility of interference of drugs in treatments, the effects will be short-term NSAIDs and COX-2 selective antiinflammatory in therapeutic doses on osteoblasts during induced tooth movement. The drugs were determined through questionnaires given to orthodontists, selecting then, the most commonly prescribed for pain relief during orthodontic treatment. The selected drugs and nimesulide (selective COX-2) were administered in a sample of 80 albino Wistar rats, in which the installation of devices consisted of an enclosed section spring anchored to the upper central incisors, moving out mesially the first upper left molar. The animals were divided into four groups of 20 according to the daily drug administration: acetaminophen, ibuprofen, nimesulide and a control group (animals not treated). Then, divided into subgroups of 5 according to the treatment time of the induced tooth movement, 3, 5 and 7 days. Subsequently, the animals received lethal doses of the mixture of anesthetic and muscle relaxant intramuscularly for the collection of the material, which has been properly processed, stained with hematoxylin-eosin and subjected to microscopic analysis to assess the amount of osteoblasts in the stressed area of the adjacent bone of each distobuccal root of the first left molars. The results showed that the use of acetaminophen up to 5 days will cause interference in bone formation decreasing the number of osteoblasts and ibuprofen was the drug that best acted by having less inhibiting action on osteoblasts in a usage period of up to 7 days. It is suggested that the ideal to relieve pain and/or discomfort caused by orthodontic movement without prejudice to the bone repair would be the use of the associated medication. On the first day, use acetaminophen...
Subject(s)
Animals , Male , Rats , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , /pharmacology , Tooth Movement Techniques , Osteoblasts , Sulfonamides/pharmacology , Acetaminophen/pharmacology , Ibuprofen/pharmacology , Osteogenesis , Rats, Wistar , Time FactorsABSTRACT
Prostaglandins control osteoblastic and osteoclastic function under physiological or pathological conditions and are important modulators of the bone healing process. The non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase (COX) activity and consequently prostaglandins synthesis. Experimental and clinical evidence has indicated a risk for reparative bone formation related to the use of non-selective (COX-1 and COX-2) and COX-2 selective NSAIDs. Ketorolac is a non-selective NSAID which, at low doses, has a preferential COX-1 inhibitory effect and etoricoxib is a new selective COX-2 inhibitor. Although literature data have suggested that ketorolac can interfere negatively with long bone fracture healing, there seems to be no study associating etoricoxib with reparative bone formation. Paracetamol/acetaminophen, one of the first choices for pain control in clinical dentistry, has been considered a weak anti-inflammatory drug, although supposedly capable of inhibiting COX-2 activity in inflammatory sites. OBJECTIVE: The purpose of the present study was to investigate whether paracetamol, ketorolac and etoricoxib can hinder alveolar bone formation, taking the filling of rat extraction socket with newly formed bone as experimental model. MATERIAL AND METHODS: The degree of new bone formation inside the alveolar socket was estimated two weeks after tooth extraction by a differential point-counting method, using an optical microscopy with a digital camera for image capture and histometry software. Differences between groups were analyzed by ANOVA after confirming a normal distribution of sample data. RESULTS AND CONCLUSIONS: Histometric results confirmed that none of the tested drugs had a detrimental effect in the volume fraction of bone trabeculae formed inside the alveolar socket.
Subject(s)
Animals , Male , Rats , Acetaminophen/adverse effects , Analgesics, Non-Narcotic/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Bone Regeneration/drug effects , /adverse effects , Ketorolac/adverse effects , Pyridines/adverse effects , Sulfones/adverse effects , Analysis of Variance , Acetaminophen/pharmacology , Analgesics, Non-Narcotic/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Cyclooxygenase 1/adverse effects , Cyclooxygenase 1/pharmacology , /pharmacology , Disease Models, Animal , Fracture Healing/drug effects , Ketorolac/pharmacology , Pyridines/pharmacology , Rats, Wistar , Sulfones/pharmacology , Time FactorsABSTRACT
A validated method using capillary electrophoresis was developed, for the determination of orphenadrine citrate in its tablet formulations, in the presence of paracetamol. The method employs a running buffer of 30 mM pentane sulfonate sodium, dissolved in 20mM MOPS buffer pH 7.7. Samples were injected using hydrodynamic sample injection mode [25 mbar, for 25s], using positive polarity of 25 kV, at a constant temperature of 30 [degree sign] C. Samples of orphenadrine citrate alone or in mixture solutions with paracetamol were exposed to various degradation conditions, and were electrophoresed using the recommended condition. The method was found to be specific, linear [r[2] =0.994], precise, accurate, and robust, with an LOQ of 0.02 mg/mL. The proposed method was successfully applied for measurement of the percentage per label of orphenadrine citrate in commercially available tablets
Subject(s)
Acetaminophen/analysis , Acetaminophen/pharmacology , Orphenadrine/pharmacology , Electrophoresis, Capillary , Chemistry, PharmaceuticalABSTRACT
Using human skin-fibroblast cell line HF2FF, the efficacy of some drugs was evaluated against sulfur mustard [SM] cytotoxicity. The drugs were the sulfhydryl containing molecule including Nacetylcysteine [NAC], 2-oxo-thiazolidine-4-carboxylate [OTC] and acetaminophen as glutathione [GSH] stimulator pathway. The protective effects of NAC [0.1 mM], OTC [1.8 mM], and acetaminophen [25 mM] alone or in combination with each other were evaluated on SM [180 micro M]-induced cytotoxicity. NAC and OTC were applied with SM simultaneously and acetaminophen 30 min before SM exposure, incubated for 1 h and then were rinsed and incubated with fresh medium. The efficacy was evaluated by determination of cells viability, intracellular GSH level and catalase activity 1 and 24 h post SM exposure or co-treatments. The cells viability was decreased 21.8% and 55.2%, respectively for 1 and 24 h post SM [1 h exposure] incubation. So, the 1-h SM exposure and 24-h treatment incubation were selected for evaluation. While, NAC alone treatment increased the cells viability [25%], GSH level [320%] and catalase activity [18%], the most effective combination was NAC plus OTC and acetaminophen which increased more significantly the cells viability [about 40%], GSH level [470%] and catalase activity [100%]. The most effective combination was NAC [0.1 mM] plus OTC [1.8 mM] and acetaminophen [25 mM] which should be used before or concomitant with SM exposure. These drugs may reduce SM toxicity possibly by increment of GSH level and catalase activity. This efficacy needs to be confirmed by in vivo study
Subject(s)
Humans , Fibroblasts/drug effects , Skin/drug effects , Cell Line/drug effects , Acetylcysteine/pharmacology , Pyrrolidonecarboxylic Acid , Thiazolidines , Acetaminophen/pharmacology , Drug Combinations , AcetaminophenABSTRACT
Analgesic and anti-inflammatory activity of aceclofenac was compared with combination of aceclofenac and paracetamol. The analgesic activity was assessed using Eddy's hot plate method and acetic acid-induced method. The anti-inflammatory activity was assessed in acute [Carrageenan-induced oedema] model of inflammation in rat. The aceclofenac and paracetamol combination showed significant analgesic and anti-inflammatory activity when compared to aceclofenac alone
Subject(s)
Animals , Acetaminophen/pharmacology , Drug Therapy, Combination , Anti-Inflammatory Agents, Non-Steroidal , Analgesics , Treatment OutcomeABSTRACT
This study was done on 60 adult patients who had day case otorhinolarngologic surgeries. Patients were allocated into three groups, according to perioperative analgesic used: Group 1 [n =20] was given 30 mg ketorolac IV, Group 2 [n=20] was given a new solubilised paracetamol formulation [Perfalgan 10mg/mi] 1gm IV infusion, and Group 3 [n=20] was given 30mg ketorolac IV plus Perfalgan 1gm IV infusion. Analgesic profiles were evaluated using the sum of pain intensity difference after 6 and 12 hours of drug intake [SPID[6and12]], the total pain relief score after 6 and 12 hours of drug intake [TOTPAR[6and12]], global patient satisfactionwith pain control, and use of rescue analgesics. Surgeons' satisfaction with intraoperative bleeding and surgical field, in addition to bleeding time were also studied as indications of tolerability to the drugs. This study demonstrated no significant differences in pain scores between ketorolac and Perfalgan, while SPID[6and12] and TOTPAR[6and12] were significantly higher in the combination group [11.6 +/- 2.1 and 20.2 +/- 4.5, p=0.01 and 0.022 respectively for SPID[6and12] and 19.6 +/- 6.2 and 39.3 +/- 8.6, p=0.001 and 0.003 respectively for TOTPAR[6and12] indicating much less pain intensity and better pain relief with the combination. In addition, fewer patients in the combination group required rescue pethidine, while no significant difference was detected in the use of rescue pethidine between the other two groups. Fourteen patients in the combination group rated their satisfaction for the analgesic regimen as very good to excellent, while only one patient in the ketorolac group had a very good response, and none of the Perfalgan group had a very good to excellent response. Surgeons' satisfaction with intraoperative surgical bleeding and surgical field was satisfactory to excellent in all groups. In addition, postoperative bleeding times in all groups did not show any significant prolongation 12 hours after discharge from recovery room. This study has demonstrated that the use of a combination of paracetamol IV infusion in the new formulation known as 'Perfalgan' Ig and IV ketorolac 30mg for control of postoperative pain in day case otorhinologic surgeries was efficient and enough to avoid the use of additional narcotics, and had a better analgesic efficacy than either drug alone, without any significant side effects on intraoperative or postoperative surgical bleeding
Subject(s)
Humans , Male , Female , Acetaminophen/pharmacology , Drug Combinations , Analgesia , Otolaryngology , Otologic Surgical Procedures , Pain, Postoperative/drug therapy , Treatment Outcome , Prospective StudiesSubject(s)
Humans , Male , Female , Child , Acetaminophen/administration & dosage , Cicatrix/etiology , Dipyrone/administration & dosage , Pain/therapy , Morphine/administration & dosage , Burns/classification , Burns/etiology , Burns/prevention & control , Acetaminophen/pharmacology , Dipyrone/pharmacology , Morphine/pharmacology , Patient Care Management , Pediatrics , Shock, Traumatic/etiologyABSTRACT
El dolor postoperatorio es todavía subvalorado en la población pediátrica. Por otro lado, entre las publicaciones que abordan el tema del dolor postoperatorio solo un 10 por ciento de ellas incluye a la población menor de 15 años. Las alternativas terapéuticas en base a analgésicos no opiaceos es restringida en niños, ya que sólo un 20 por ciento del total de las drogas disponibles en el mercado ha probado su eficacia y seguridad en esta población. un analgésico antiguo es el acetaminofeno, acumulando la mayor cantidad de estudios. Los antinflamatorios no esteriodales (AINEs) han ganado popularidad en el manejo del dolor postoperatorio pediátrico. El objetivo de esta revision es determinar cuáles son las indicaciones y las dosis mas racionales y seguras para el tratamiento del dolor agudo en niños.
Postoperatory pain is still subvaluated in pediatric population. On the other hand, only 10 percent of publications discussing postoperatory pain subjects includes a population under age 15. Therapeutic alternatives based on nonopiate analgesics are restrained for children as only 20 percent of the total available drugs in the market has proven their efficacy and safety in children. An old analgesic is acetaminophen, which accumulates most part of studies. Nonsteroidal antinflammarory drugs (NSAI) are gaining popularity to manage postoperatory pain in children. The objective of this revision is to determine the most rational and safest indications and dosages when treating acute pain in children.